Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.000
+0.044 (4.62%)
At close: Nov 20, 2024, 4:00 PM
1.030
+0.030 (3.00%)
After-hours: Nov 20, 2024, 7:44 PM EST
Lucid Diagnostics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Lucid Diagnostics stock have an average target of 3.69, with a low estimate of 2.00 and a high estimate of 7.25. The average target predicts an increase of 269.00% from the current stock price of 1.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LUCD stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $3 → $2 | Buy | Maintains | $3 → $2 | +100.00% | Nov 15, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +200.00% | Nov 14, 2024 |
| Needham | Needham | Strong Buy Reiterates $2.5 | Strong Buy | Reiterates | $2.5 | +150.00% | Nov 14, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7.5 → $7.25 | Strong Buy | Maintains | $7.5 → $7.25 | +625.00% | Sep 10, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +200.00% | Aug 13, 2024 |
Financial Forecast
Revenue This Year
4.58M
from 2.43M
Increased by 88.47%
Revenue Next Year
15.51M
from 4.58M
Increased by 238.94%
EPS This Year
-1.00
from -1.26
EPS Next Year
-0.71
from -1.00
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.0M | 38.3M | 94.3M | ||
| Avg | 4.6M | 15.5M | 49.7M | ||
| Low | 3.9M | 6.9M | 16.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 105.3% | 736.8% | 507.9% | ||
| Avg | 88.5% | 238.9% | 220.6% | ||
| Low | 61.4% | 49.9% | 8.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.91 | -0.57 | 0.09 | ||
| Avg | -1.00 | -0.71 | -0.35 | ||
| Low | -1.07 | -0.74 | -0.65 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.